We have stayed positive on Nebius Group N.V. (NBIS), though in the past we have encouraged waiting for a pullback. We got that pullback in June-July, which set up a nice buying opportunity. The stock, ...

CoreWeave stock is rising as investors see a path to profitability with the company's adjusted operating margin rising from 1% to 5% and faster revenue growth ahead ...

CoreWeave just posted a quarter that sent shares surging nearly 20%, but the same report that thrilled bulls also revealed a debt spiral growing faster than the revenue chasing it.

We’re talking about Situational Awareness, a hedge fund run by a guy named Leopold Aschenbrenner, which made a huge bet on the future of A.I.

Shenzhen, China-based Tencent (HK:700), which according to OpenRouter has the second-most used large language model this week, said its capital expenditure surged 176% year-on-year, to 52.8 billion ...

AUSTIN, Texas and NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) today reported financial and operating results for the second quarter 2026 ...

Increased demand from AI labs, hyperscalers and enterprises led CoreWeave's revenue backlog to reach $104 billion at the end of the second quarter, up 246% from a year prior. Additionally, over $25 ...

Related: Florida Has A 63-Year-Old Deli Where Gourmet Sandwiches Still Cost Under $15 Sebring is famous for its legendary 12 Hours of Sebring race, but the real story here is how much good living you ...

(NYSE: INFQ) ("Infleqtion" or the "Company"), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today reported record second-quarter 2026 revenue of $12.6 ...

Second-quarter consolidated revenue reached a record of $2.46 million, representing an increase of 35.8% from $1.81 million in the first quarter of 2026 and an increase of 1,337% from $0.17 million in ...

In May, the Company announced that the U.S. Food and Drug Administration (FDA) held a Type C meeting in late March 2026 focused on the ELPIS II Phase 2b clinical trial and upcoming data readout.

CoreWeave shares surged about 14% after hours as Q2 revenue rose 112% to a record $2.58 billion and its AI cloud revenue backlog reached $104.2 billion.